Lei Zhou, Hao Wang, Yaping Li
文献索引:10.7150/thno.22679
全文:HTML全文
Chemotherapy is still a main option for cancer therapy, but its efficacy is often unsatisfying due to multidrug resistance (MDR). The tumor microenvironment is considered a dominant factor causing MDR. Stimuli-responsive nanomedicines exhibit many superiorities for reversal of MDR. As smart systems, stimuli-responsive nanomedicines are desirable for achieving site-specific accumulation and triggered drug release in response to slight changes in physicochemical properties in pathological conditions or to exogenous stimuli. In this review, we highlight the current progress of various nanomedicines with different stimuli-responsive capabilities for overcoming MDR. The materials, design, construction as well as efficacy in overcoming MDR of these nanomedicines are discussed. Eventually, we look forward to forthcoming intelligent nanoparticle systems with new mechanisms to deliver drugs for practical applications in conquering cancer MDR.
Diagnosis of LVAD Thrombus using a High-Avidity Fibrin-Speci...
2018-02-02 [10.7150/thno.20271] |
LncRNA PFL contributes to cardiac fibrosis by acting as a co...
2018-02-02 [10.7150/thno.20846] |
Delivery of Sonic Hedgehog Gene Repressed Irradiation-induce...
2018-01-13 [10.7150/thno.23373] |
Non-invasive monitoring of in vivo hydrogel degradation and ...
2018-01-13 [10.7150/thno.22514] |
Biomimetic nanoparticles with enhanced affinity towards acti...
2018-01-05 [10.7150/thno.22078] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved